SK LIFE SCIENCE LABS
LIVE

Serial Number

98243542

Owner

SK Inc.

Attorney

Hun Joon Kim

Filing Date

Oct 27, 2023

Add to watchlist:

No watchlists yet
View on USPTO

SK LIFE SCIENCE LABS Trademark

Serial Number: 98243542 • Registration: 8007507

SK LIFE SCIENCE LABS is a trademark filed by SK Inc. on October 27, 2023. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

SK Inc. (221 trademarks)

26, Jong-ro, Jongno-gu

Entity Type: 03

Trademark Details

Filing Date

October 27, 2023

Registration Date

November 4, 2025

Published for Opposition

June 24, 2025

Goods & Services

Medicines for human purposes for the treatment and prevention of central nervous system diseases, cancer, metabolic diseases, allergy, immunological diseases and disorders, neurological diseases and disorders, cardiac diseases and disorders, dermatological diseases and disorders, endocrinological diseases and disorders, gastroenterological diseases and disorders, hematological diseases and disorders, infectious diseases and disorders, genetic diseases and disorders, nephrological diseases and disorders, gynecological diseases and disorders, ophthalmological diseases and disorders, orthopedic diseases and disorders, otorhinolaryngological diseases and disorders, podiatric diseases and disorders, psychiatric diseases and disorders, pulmonological diseases and disorders, respiratory diseases and disorders, rheumatological diseases and disorders, urological diseases and disorders, and auto-immune diseases and disorders; chemical preparations for pharmaceutical purposes, namely, for the treatment and prevention of central nervous system diseases, cancer, metabolic diseases, allergy, immunological diseases and disorders, neurological diseases and disorders, cardiac diseases and disorders, dermatological diseases and disorders, endocrinological diseases and disorders, gastroenterological diseases and disorders, hematological diseases and disorders, infectious diseases and disorders, genetic diseases and disorders, nephrological diseases and disorders, gynecological diseases and disorders, ophthalmological diseases and disorders, orthopedic diseases and disorders, otorhinolaryngological diseases and disorders, podiatric diseases and disorders, psychiatric diseases and disorders, pulmonological diseases and disorders, respiratory diseases and disorders, rheumatological diseases and disorders, urological diseases and disorders, and auto-immune diseases and disorders; sanitary preparations for medical purposes; ferments for pharmaceutical purposes; pharmaceutical preparations, namely, immunomodulators; vitamin preparations; vaccines; nutritional additives in the nature of dietary supplements for use in foods for human consumption; bacteriological preparations for medical and veterinary use; veterinary preparations for the treatment of diseases or conditions of the respiratory system, diseases or conditions of the cardiovascular system, diabetes, cancer, arthritis, diseases or conditions of the gastro-intestinal system, diseases or conditions of the central nervous system, diseases or conditions of the endocrine system, diseases or conditions of the genito-urinary system, infections, skin disorders and gynecological conditions

Technical project studies, namely, conducting clinical trials for others; development of new technology for others in the field of biotechnology; biotechnology research; biotechnology services, namely, research and development in the biotechnology fields; biotechnology services, namely, providing information on the subject of scientific research in the field of biotechnology; biochemical analysis; research and development of new products for others; research relating to pharmaceuticals; product development consultation, namely, analysis and evaluation of medical product development; testing, inspection or research of pharmaceuticals; pharmaceutical product evaluation; medical research; chemical research; development and test of chemical production methods

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Nov 4, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
Nov 4, 2025 R.PR
WITHDRAWN FROM ISSUE - OG REVIEW QUERY
Aug 5, 2025 ISCR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jun 24, 2025 NPUB
PUBLISHED FOR OPPOSITION
Jun 24, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jun 18, 2025 NONP
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
May 30, 2025 ERRR
APPROVED FOR PUB - PRINCIPAL REGISTER
May 15, 2025 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
May 14, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 14, 2025 CRFA
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
May 14, 2025 ERSI
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Mar 3, 2025 GNS2
INQUIRY TO SUSPENSION E-MAILED
Mar 3, 2025 GNSI
SUSPENSION INQUIRY WRITTEN
Mar 3, 2025 CNSI
ASSIGNED TO EXAMINER
Mar 3, 2025 DOCK
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 17, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 17, 2024 CRFA
ASSIGNED TO LIE
Dec 17, 2024 ALIE
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Nov 15, 2024 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Nov 15, 2024 ECDR
TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED
Nov 15, 2024 EWOR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Nov 15, 2024 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Nov 15, 2024 REAP
ASSIGNED TO EXAMINER
Sep 29, 2024 DOCK
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Jun 1, 2024 GNS3
LETTER OF SUSPENSION E-MAILED
Jun 1, 2024 GNSL
SUSPENSION LETTER WRITTEN
Jun 1, 2024 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 3, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 2, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 2, 2024 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Feb 7, 2024 GNRN
NON-FINAL ACTION E-MAILED
Feb 7, 2024 GNRT
NON-FINAL ACTION WRITTEN
Feb 7, 2024 CNRT
ASSIGNED TO EXAMINER
Jan 29, 2024 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Nov 7, 2023 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 6, 2023 NWOS
NEW APPLICATION ENTERED
Oct 31, 2023 NWAP